Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa by Regan, Susan et al.
 
Factors Associated with Self-Reported Repeat HIV Testing after a
Negative Result in Durban, South Africa
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Regan, Susan, Elena Losina, Senica Chetty, Janet Giddy, Rochelle
P. Walensky, Douglas Ross, Helga Holst, Jeffrey N. Katz,
Kenneth A. Freedberg, and Ingrid V. Bassett. 2013. Factors
associated with self-reported repeat hiv testing after a negative
result in durban, south africa. PLoS ONE 8(4): e62362.
Published Version doi:10.1371/journal.pone.0062362
Accessed February 19, 2015 12:04:56 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11180403
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAFactors Associated with Self-Reported Repeat HIV
Testing after a Negative Result in Durban, South Africa
Susan Regan
1,10*, Elena Losina
1,2,3,8,10, Senica Chetty
4, Janet Giddy
4, Rochelle P. Walensky
1,5,6,8,10,
Douglas Ross
7, Helga Holst
4, Jeffrey N. Katz
2,9, Kenneth A. Freedberg
1,5,8,9,10, Ingrid V. Bassett
1,5,10
1Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 2Division of Rheumatology, Department of Medicine,
and Department of Orthopedic Surgery, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 3Department of Biostatistics, Boston University
School of Public Health, Boston, Massachusetts, United States of America, 4McCord Hospital, Durban, South Africa, 5Division of Infectious Disease, Massachusetts General
Hospital, Boston, Massachusetts, United States of America, 6Division of Infectious Disease, Brigham and Women’s Hospital, Boston, Massachusetts, United States of
America, 7St. Mary’s Hospital, Mariannhill, Durban, South Africa, 8Harvard University Center for AIDS Research (CFAR), Boston, Massachusetts, United States of America,
9Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, 10Medical Practice Evaluation Center, Department of
Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America
Abstract
Background: Routine screening for HIV infection leads to early detection and treatment. We examined patient
characteristics associated with repeated screening in a high prevalence country.
Methods: We analyzed data from a cohort of 5,229 adults presenting for rapid HIV testing in the outpatient departments of
2 South African hospitals from November 2006 to August 2010. Patients were eligible if they were $18 years, reported no
previous diagnosis with HIV infection, and not pregnant. Before testing, participants completed a questionnaire including
gender, age, HIV testing history, health status, and knowledge about HIV and acquaintances with HIV. Enrollment HIV test
results and CD4 counts were abstracted from the medical record. We present prevalence of HIV infection and median CD4
counts by HIV testing history (first-time vs. repeat). We estimated adjusted relative risks (ARR’s) for repeat testing by
demographics, health status, and knowledge of HIV and others with HIV in a generalized linear model.
Results: Of 4,877 participants with HIV test results available, 26% (N=1258) were repeat testers. Repeat testers were less
likely than first-time testers to be HIV-infected (34% vs. 54%, p,0.001). Median CD4 count was higher among repeat than
first-time testers (201/uL vs. 147/uL, p,0.001). Among those HIV negative at enrollment (N=2,499), repeat testing was more
common among those with family or friends living with HIV (ARR 1.50, 95% CI: 1.33–1.68), women (ARR: 1.24, 95% CI: 1.11–
1.40), and those self-reporting very good health (ARR: 1.28, 95% CI: 1.12–1.45).
Conclusions: In this high prevalence setting, repeat testing was common among those undergoing HIV screening, and was
associated with female sex, lower prevalence of HIV infection, and higher CD4 counts at diagnosis.
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Introduction
Routine screening for HIV infection can lead to earlier
detection and treatment compared to screening only those
experiencing symptoms of infection [1]. Repeated screening for
HIV has been linked to higher CD4 cell counts when HIV
infection is diagnosed which, if followed by prompt treatment with
antiretroviral therapy, in turn reduces mortality [2,3]. Because
treatment lowers viral load and infectivity, a further benefit of
early detection is reduced transmission of the virus [4].
WHO guidelines recommend routine screening for HIV in high
prevalence areas.
In South Africa, national prevalence was 17% among those 15
to 49 years old in 2008, but was as high as to 26% in KwaZulu
Natal (KZN) Province [5]. Young women are the most affected
group, with prevalence of 33% among 25 to 29 year old females
[5]. The South African National Strategic Plan (2007) [6] had
ambitious goals including screening 25% of the population each
year. The result has been a marked increase in HIV testing,
especially among women. In 2008, 57% of women and 43% of
men had ever been tested and 29% of women and 20% of men
had been tested in the prior 12 months [7]. Higher rates of testing
have been found among women of childbearing age and those
with young children [8].
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e62362There are many barriers to HIV testing, including concerns
about privacy and stigmatization [9,10], lack of understanding of
how HIV is transmitted, fear that one is infected [11,12] or belief
that one is not at risk for infection [12,13,14] and lack of
knowledge about or access to treatment [15,16,17]. Acceptance of
repeat testing further requires acknowledging that one remains at
risk for future infection even after having received a reassuring
negative result. Indeed, having been tested previously is a common
reason for refusing a subsequent HIV test [13,14,18].
We conducted an observational study of patients presenting for
HIV testing at the outpatient departments of two hospitals in KZN
to assess HIV prevalence, assessing characteristics associated with
repeat testing in this high prevalence setting. We compared those
testing for the first time with those reporting having previously
tested negative for HIV (repeat testers) to examine factors
associated with repeat testing. We considered factors shown to
predict HIV prevalence or first-time testing rates: demographics,
knowledge of HIV [19] and friends or family living with HIV [20],
and the circumstances of testing (provider-initiated, opt-out) [1].
We hypothesized that repeat testing would be more common
among those who were younger and female, since pregnancy is
a common occasion for HIV screening.
Methods
Setting and Participants
We analyzed data from the South African Test, Identify and
Link (STIAL) Cohort which has been described in detail elsewhere
[21,22]. The cohort comprises adults who presented for HIV
testing at the outpatient departments of two South African
hospitals between November 2006 and August 2010. The
participating hospitals were McCord Hospital, located in Durban
(the urban site), and St Mary’s Hospital Mariannhill, in a largely
rural area outside Durban (the rural site). Patients paid a fee for
care in the outpatient department of 140–200 ZAR (US$18-26) at
McCord Hospital and 50–70 ZAR (US$6-9 2008) at St Mary’s
Hospital. Both hospitals changed from testing by physician referral
to an opt-out HIV testing policy approximately one year into the
study period. Under opt-out testing, dedicated counselors placed
in the outpatient departments offered patients tests prior to their
clinician visit. Both before and after the opt-out policy was
adopted, patients were able to self-present for testing, independent
of a clinician referral.
Patients were eligible for enrollment if, based on self-report, they
had not been found to be HIV-infected in any previous test, were
18 years of age or older, Zulu or English speakers, not pregnant,
were willing to share their HIV test results with study staff, and
had no cognitive limitations that precluded giving informed
consent. Patients who were confined to a stretcher or wheelchair
were excluded to prevent study participation from interfering with
their need for immediate care.
Ethics Statement
The study was approved by the Ethics Committees of McCord
Hospital and St. Mary’s Hospital Mariannhill, and the Partners
HealthCare Human Research Committee in Boston, MA, USA.
All participants provided written, informed consent.
Screening Protocol
Patients were approached by study staff while they were waiting
to undergo rapid HIV testing. Before the test and after giving
informed consent, participants completed an orally administered
questionnaire in Zulu or English. The questionnaire included:
N demographics: gender, age, and parental status (with or without
children)
N current health status: self-assessed as very good, good, fair, poor,
or bad
N reason for having the HIV test that day: referred by a healthcare
provider vs. self-initiated testing
N awareness of others living with HIV: awareness of family, friends, or
co-habitants infected with HIV
N knowledge about HIV: agreement or disagreement with a series of
4 statements about HIV. A knowledge score was calculated as
the number of items correct (range: 0–4). The statements were:
‘‘There are medicines available to help people with HIV live
longer’’; ‘‘A person with HIV can look and feel healthy’’;
‘‘There is a vaccine/medicine that can stop people from
getting HIV’’; and ‘‘All women who are HIV positive will have
babies born with HIV’’.
N prior HIV testing history: self-report of ever testing for HIV before
anywhere, and if so, the number of times previously tested.
Participants usually received their HIV test results within 30
minutes. Those found to be HIV-infected were referred to the
HIV clinic at the site and offered CD4 testing that day, with results
available within 2 weeks. Medical record review was conducted to
obtain HIV test results and CD4 counts performed within 12
weeks of enrollment.
Statistical Analyses
Participants for whom a conclusive HIV test result was not
available were excluded from analyses. We present prevalence of
HIV infection by prior testing status at enrollment and median
CD4 counts for those who were HIV-infected. Difference in prior
testing rates was assessed using chi-squared tests. Differences in
median CD4 counts were tested using a Wilcoxon rank-sum test.
We obtained the HIV status at enrollment from the medical
record but relied on participant self-report for history of prior
testing and test results. In analyses of factors associated with testing
after a prior negative result, we excluded those who tested HIV-
infected at enrollment because, among this group, we cannot be
certain that all prior HIV test results were negative. Among
participants HIV negative at enrollment, we know that the results
of all prior tests were negative and therefore the enrollment test
represents a test after a prior negative result.
We assessed differences in participant characteristics between
those who did and did not report having had a prior HIV test
using chi-squared tests, except for knowledge score which was
tested using a Wilcoxon rank-sum test. Participant age was
dichotomized at the median (,35 vs. .=35 years). We
dichotomized self-assessed health status as very good vs. all other.
Linear trends in percent reporting prior testing by health self-
ratings were assessed with logistic regression.
We estimated relative risks (RR’s) and 95% confidence intervals
(CI) for prior testing by participant characteristics using a gener-
alized linear model with a poisson distribution, a log link function
and robust standard errors. We also present adjusted relative risks
(ARR’s) and CI’s for these characteristics from a model predicting
prior testing that includes participant gender, age group, reason
for HIV testing, awareness of friends or family members with HIV
infection, and knowledge of HIV and enrollment site (rural vs.
urban).
All analyses were performed using Stata statistical software
(StataCorp, 2008. Stata Statistical Software: Release 10. College
Station, TX: Stata Corporation).
Repeat HIV Testing after a Negative Result
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Enrollment and Testing
Between November 2006 and August 2010, 5,728 patients were
screened, of whom 93% (5,300/5,728) were eligible (Figure 1).
Nearly all (99%, 5,229/5,300) of those eligible enrolled. Conclu-
sive enrollment HIV test results were available for 4,877
participants (93%, 4,877/5,229), of whom approximately half
(49%, 2,370/4,877) were HIV-infected. Overall, a quarter of
participants reported having been tested for HIV prior to
enrollment (26%, 1,258/4,877, Table 1). Compared to those
having their first HIV test, repeat testers were less likely to be
HIV-infected at enrollment (34% vs. 54%, p,0.001).
Repeat Testing and CD4 Counts
CD4 counts were available for 61% (1,436/2,370) of those
found HIV-infected. Median CD4 count was higher among those
reporting a previous negative HIV test (201/ml, IQR: 90–366
cells/ml) than those reporting no previous test (147/ml, IQR: 58–
286/ml, p,0.001). Participants with two or more previous tests
had a higher median CD4 count than those with only one previous
test, but this difference was not statistically significant (235/ml,
IQR: 128–514, vs. 198/ml, IQR: 87–360, p=0.12).
Factors Associated with Prior Testing
Of those participants who were HIV-negative at enrollment,
approximately half were women, less than 35 years old, self-
referred for testing and enrolled at the rural site (Table 2). The
mean HIV knowledge score was 3.3, indicating that participants
answered more than 3 of 4 questions correctly on average. Only
20% reported being aware that someone they knew was HIV-
infected.
In bivariate analyses, participants with prior testing differed
significantly from those with no prior testing on all characteristics
examined, with those reporting prior testing having a higher mean
HIV knowledge score and being more likely to be women, to be
under 35 years old, to know someone with HIV, to have referred
themselves for HIV testing, to report being in very good health, to
have enrolled at the rural hospital and to have enrolled after the
opt-out policy began.
A multivariate model of repeat testing was assessed including all
factors in Table 2. Fifty-nine participants were missing a value for
one of the factors and were excluded from the analysis. All factors
remained statistically significant in the multivariate analysis except
for age group. Being aware of a friend or family member with HIV
was associated with a 50% higher rate of prior testing (ARR: 1.50,
95% CI: 1.33–1.68). Higher rates of prior testing were also
associated with being female (ARR: 1.24 (1.11–1.40), self-referring
for testing (ARR: 1.28, 95% CI: 1.14–1.43), reporting very good
health (ARR: 1.28, 95% CI: 1.12–1.45) and having higher HIV
knowledge scores (ARR: 1.10, 95% CI: 1.03–1.18).
Women were more likely than men to report a prior HIV test
(37% vs. 29%, p,.001), but the gender difference was confined to
younger women. Figure 2 depicts prior testing rates by gender, age
group and parental status (any children vs. no children). The
highest rate of prior testing (55%) was observed among women
under 35 years old with children, while rates did not differ
significantly among the other groups.
Figure 1. Cohort Enrollment and Testing.
doi:10.1371/journal.pone.0062362.g001
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increasing self-assessed health status from 27% among those
reporting the poorest health to 54% among those describing their
health as very good, (p,0.001, Figure 3). Similarly, the rate of
reporting two or more prior tests increased with health self-rating,
from 9% of those with poor health to 31% of those with very good
health (p,0.001).
Discussion
In this observational study of a large cohort of outpatients
seeking HIV testing in Durban, South Africa, we found a very
high prevalence of HIV infection. Twenty-six percent of those
enrolled were repeat testers, and repeat testing was more common
in those who were not infected at enrollment (33% compared to
18% for those HIV-infected). Among those HIV-infected at
enrollment, CD4 cell counts were quite low, but significantly
higher in repeat testers (201 vs. 147/ml). We found repeat testing
was associated with demographic characteristics, specifically
younger age and female gender, and with knowing someone
living with HIV. Repeat testing was less common among those
referred by healthcare workers compared to self-referred partic-
ipants yet more common when the clinic had a routine, opt-out
testing policy. Prior testing and the number of prior tests were
positively associated with self-rated health status.
Cross-sectional community-based surveys indicate that a sub-
stantial proportion of the population in sub-Saharan Africa have
been tested for HIV at least once. Nearly half of those reached in
a population-based survey in Botswana [12] reported having had
an HIV test. In a rural community in South Africa, rates varied
with gender, with 39% of women but only 17% of men surveyed
reporting have been tested [8]. Repeat testers have been observed
in relatively high proportions among those presenting for testing in
some settings. A population-based study conducted in a peri-urban
community in SA found 71% of those who responded to a request
to report for HIV testing had been tested before [23]. At a mobile
clinic in Capetown, SA, 58% of men being screened were repeat
testers [24], and a similar rate was seen among all testers at a rural
Zambian clinic [25]. In contrast, in an earlier study of our urban
hospital, the rate was 35% [17] and the present study found only
a quarter of participants were repeat testers. It may be that local
factors like testing venue, attitudes [26] and background HIV
prevalence [27] influence the observed rates of repeat testing.
Delayed diagnosis of HIV infection can have a serious negative
impact on treatment outcomes. Patients with CD4 counts under
Table 1. HIV status and CD4 count among those HIV-infected at enrollment by HIV testing history.
HIV Testing History Total HIV Status CD4 Count
Not Infected Infected N Median IQR*
N% N % N%
First-time tester 3,600 74 1,669 46 1,931 54 1,183 147 58–286
Repeat tester 1,258 26 830 66 428 34 246 201 90–366
1 previous test 765 16 436 57 329 43 199 198 87–360
2 or more previous tests 493 10 394 80 99 20 47 235 128–514
Unknown testing history 19 ,1 8 42 11 58 7 159 51–342
Total 4,877 100 2,507 51 2,370 49 1,436 156 62–298
*IQR: interquartile range.
doi:10.1371/journal.pone.0062362.t001
Table 2. Characteristics of participants HIV negative at enrollment.
Characteristic Total Tested prior to enrollment RR* (95% CI) ARR** (95% CI)
No Yes P***
N( % ) N( % ) N( % )
Female 1,400 (56) 887 (53) 513 (62) ,0.001 1.27 (1.13–1.43) 1.24 (1.11–1.40)
Age ,35 years 1,114 (45) 696 (42) 418 (51) ,0.001 1.28 (1.14–1.43) 1.10 (0.98–1.23)
Very good health 395 (16) 182 (11) 213 (26) ,0.001 1.84 (1.64–2.06) 1.28 (1.12–1.45)
Self-referred for enrollment testing 1,117 (45) 633 (38) 484 (59) ,0.001 1.74 (1.55–1.95) 1.28 (1.14–1.43)
Family/friend with HIV 495 (20) 205 (12) 290 (35) ,0.001 2.18 (1.97–2.42) 1.50 (1.33–1.68)
HIV knowledge score (mean, SD) 3.3 (1.01) 3.3 (1.08) 3.4 (0.83) ,0.001 1.12 (1.05–1.19) 1.10 (1.03–1.18)
Rural site 1,099 (44) 558 (33) 541 (65) ,0.001 2.38 (2.12–2.69) 1.98 (1.72–2.28)
Tested under opt-out policy 1,970 (79) 1,236 (74) 734 (88) ,0.001 2.05 (1.70–2.48) 1.51 (1.25–1.83)
Total 2,499 1,669 (67) 830 (33)
*RR: unadjusted relative risk for prior testing.
**ARR: adjusted relative risk for prior testing, adjusted for all characteristics shown.
***P for bivariate comparison.
doi:10.1371/journal.pone.0062362.t002
Repeat HIV Testing after a Negative Result
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e62362200 at diagnosis have much higher mortality rates [3] and are
more likely to be diagnosed with an AIDS-defining illness [28].
Frequent, repeated HIV screening can shorten the period from
infection to diagnosis, as seen in our HIV-infected repeat testers
who had higher CD4 counts than the first time testers, and offers
the hope of preventing disease progression and mortality [2].
Opt-out or provider-initiated testing policies have been im-
plemented to promote HIV testing in high prevalence settings.
These programs incorporate testing into routine visits, thereby
reducing both logistical barriers and destigmatizing HIV screen-
ing. Such efforts have generally resulted in markedly greater
uptake of HIV testing, although to varying degrees [17,29], and
may yield more late-stage diagnoses compared to voluntary
Figure 2. Percent with prior HIV test among those HIV negative at enrollment, by gender, age group, and parental status.
doi:10.1371/journal.pone.0062362.g002
Figure 3. Percent with prior HIV test among those HIV negative at enrollment, by self-reported health status (linear trend p,.001).
doi:10.1371/journal.pone.0062362.g003
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patients who are already connected to health services, they may be
especially likely to reach those who have already been tested for
HIV and promote repeat testing. Patients who have come to view
HIV screening as routine care may be comfortable requesting
screening in settings lacking an opt-out policy. We found the
highest rate of repeat testing among younger women with
children, a group whose HIV screening rates have been boosted
by provider-initiated prenatal screening programs [8]. The women
in our study were not pregnant at the time they presented for the
enrollment test which suggests that the increasingly common
experience of testing during pregnancy may promote acceptance
of the notion of HIV screening as routine healthcare.
Basic knowledge about HIV transmission and treatment was
high among our participants, with many correctly answering all
the HIV knowledge items. Only 20% reported that they knew
someone living with HIV, a remarkably low figure given the size
and duration of the HIV epidemic in KZN, suggesting disclosure
of HIV status is not common. This is consistent with a recent
qualitative study in KZN which found reluctance to screen for
HIV because of fear of discrimination, even within a community
that is well-informed about HIV [16]. Education about HIV is not
sufficient to eliminate the social costs of learning one is infected.
Repeat testing was more common among those who acknowl-
edged knowing someone living with HIV. This may be the result
of perceived vulnerability to HIV infection because of a personal
connection to an infected person. It might also indicate a relative
normalization of HIV screening due to social proximity to
someone who has disclosed being HIV-infected.
It is notable that any prior testing and multiple prior tests were
associated with greater feelings of well-being. This may in part
reflect that people feel healthy when they have had one or more
negative HIV test results, but it also shows a continued willingness
to test despite feeling healthy and implies an understanding that
a person who feels well can be HIV-infected. Screening people
who feel well is one key to earlier diagnosis of infection.
This study has a number of limitations. It is an observational
study in which we rely on self-report for participants’ testing
history. It is possible that participants who indicated that they were
first-time testers had actually previously tested positive for HIV but
were unwilling to disclose that information, which would falsely
increase the difference in prevalence between first-time and repeat
testers. CD4 counts were unavailable for 40% of those who were
HIV-infected. During the study period, both of the hospitals
implemented an opt-out HIV testing policy. We include this factor
in our multivariate model to attempt to control for it, but testing
policy is confounded with time, and it is possible that some of the
increase in repeat testing associated with the opt-out policy is due
to temporal trends in testing. Finally, we were unable to examine
the effect of proximity to a testing site on HIV testing behavior.
In summary, in two hospitals in KZN with a high prevalence of
HIV infection, a quarter of those presenting for HIV testing had
previously tested negative. Repeat testers found to be HIV-
infected at enrollment had higher CD4 counts at detection. A
history of prior testing was more common among young women,
those who know someone living with HIV, and those with good
self-rated health status. Repeat testing increased when opt-out
testing was implemented. Routine screening is beneficial, resulting
in earlier detection. Future research should be directed toward
determining optimal retesting frequencies for high prevalence
settings.
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